EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Penehyclidine hydrochloride protects against lipopolysaccharide-induced acute lung injury by promoting the PI3K/Akt pathway

Junting Weng iD, Danjuan Liu, Bingbing Shi, Min Chen, Shuoyun Weng, Rongjie Guo, Chunjin Fu iD

International Journal of Immunopathology and Pharmacology · 2023

DOI: 10.1177/03946320231192175 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Immunopathology and Pharmacology, 2023. Verfasst von Junting Weng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, The Affiliated Hospital of Putian University, Putian, China. Hauptthemen laut MEDLINE: Lipopolysaccharides, Acute Lung Injury. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The Science and Technology Project of Putian City, Fujian Province, Natural Science Foundation of Fujian Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Acute lung injury (ALI) attracted attention among physicians because of its high mortality. We aimed to determine whether the phosphatidylinositol-3 kinase (PI3K)/protein kinase B (Akt) pathway is involved in the protective effects of penehyclidine hydrochloride (PHC) against lipopolysaccharide (LPS)-induced ALI.

Methods

H&E staining was used to observed pathological changes in the lung tissues. ELISA was used to evaluate the concentration of inflammatory mediators in the bronchoalveolar lavage fluid (BALF). White-light microscopy was performed to observe the TUNEL-positive nuclei. The viability of NR8383 alveolar macrophages was determined by using CCK-8. The levels of MPO, MDA, SOD, and GSH-Px were analyzed using ELISA kits. Western blotting was used to evaluate the ERS-associated protein levels and the phosphorylation of PI3K and Akt.

Results

PHC administration defended against LPS-induced histopathological deterioration and increased pulmonary edema and lung injury scores, while all of these beneficial effects were inhibited by LY. In addition, PHC administration mitigated oxidative stress as indicated by decreases in lung myeloperoxidase (MPO) and malondialdehyde (MDA) concentrations, and increases in glutathione peroxidase (GSH-Px) and superoxide dismutase (SOD) concentrations. It also alleviated LPS-induced inflammation. PHC administration attenuated apoptosis-associated protein levels, improved cell viability, and decreased the number of TdT-mediated dUTP Nick-End Labeling (TUNEL)-positive cells. Furthermore, PHC inhibited ERS-associated protein levels. Meanwhile, the protection of PHC against inflammation, oxidative stress, apoptosis, and ERS was inhibited by LY. Moreover, PHC administration increased PI3K and Akt phosphorylation, indicating that the upregulation of the PI3K/Akt pathway, while this pathway was inhibited by LY.

Conclusion

PHC significantly activates the PI3K/Akt pathway to ameliorate the extent of damage to pulmonary tissue, inflammation, oxidative stress, apoptosis, and ERS in LPS-induced ALI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LipopolysaccharidesAcute Lung InjuryRatsAnimalsProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesPhosphatidylinositol 3-KinaseRats, Sprague-DawleyLungInflammationSuperoxide DismutaseQuinuclidines

Stichwörter der Autor:innen

PI3K/Aktacute lung injuryapoptosisendoplasmic reticulum stresspenehyclidine hydrochloride

Substanzen

LipopolysaccharidesProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesPhosphatidylinositol 3-KinaseSuperoxide DismutasepenehyclidineQuinuclidines

Autor:innen und Institutionen

  • Department of Critical Care Medicine, The Affiliated Hospital of Putian University, Putian, China.
  • School of Wenzhou Medical University, Wenzhou, China.

ORCID-Profile: Junting Weng, Chunjin Fu

Förderung

  • The Science and Technology Project of Putian City, Fujian Province
  • Natural Science Foundation of Fujian Province

Zitieren

APA

Weng, J., Liu, D., Shi, B., Chen, M., Weng, S., Guo, R., & Fu, C. (2023). Penehyclidine hydrochloride protects against lipopolysaccharide-induced acute lung injury by promoting the PI3K/Akt pathway. International Journal of Immunopathology and Pharmacology. https://doi.org/10.1177/03946320231192175

Vancouver

Weng J, Liu D, Shi B, Chen M, Weng S, Guo R, et al. Penehyclidine hydrochloride protects against lipopolysaccharide-induced acute lung injury by promoting the PI3K/Akt pathway. International Journal of Immunopathology and Pharmacology. 2023. doi:10.1177/03946320231192175

BibTeX
@article{Weng2023,
  author = {Weng, Junting and Liu, Danjuan and Shi, Bingbing and Chen, Min and Weng, Shuoyun and Guo, Rongjie and Fu, Chunjin},
  title = {Penehyclidine hydrochloride protects against lipopolysaccharide-induced acute lung injury by promoting the PI3K/Akt pathway},
  journal = {International Journal of Immunopathology and Pharmacology},
  year = {2023},
  doi = {10.1177/03946320231192175}
}
Kostenlos starten →